MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Sorrento Therapeutics Company Profile (NASDAQ:SRNE)

Consensus Ratings for Sorrento Therapeutics (NASDAQ:SRNE) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $26.67 (107.04% upside)

Analysts' Ratings History for Sorrento Therapeutics (NASDAQ:SRNE)
Show:
DateFirmActionRatingPrice TargetActions
8/10/2015Brean CapitalReiterated RatingBuy$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/3/2015MLV & Co.Initiated CoverageBuy$34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2015Brean CapitalBoost Price TargetBuy$17.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/10/2015HC WainwrightReiterated RatingBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/30/2015MLV & Co.Reiterated RatingBuy$33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2015MLV & Co.Reiterated RatingBuy$25.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/28/2015Brean CapitalInitiated CoverageBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2015HC WainwrightReiterated RatingBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2015HC WainwrightBoost Price TargetBuy$13.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2014HC WainwrightSet Price TargetBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2014MLV & Co.Set Price TargetBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/15/2014AegisReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2014HC WainwrightInitiated CoverageBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2014MLV & Co.Initiated CoverageBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2013Capital Ideas ResearchInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2013AegisInitiated CoverageBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/20/2013CRT CapitalInitiated CoverageBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/5/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha